Navigation Links
Osteotech Reports First Quarter 2009 Financial Results
Date:4/30/2009

$(.10) $.05 Shares used in computing earnings (loss) per share: Basic 17,874,236 17,716,902 Diluted 17,874,236 17,906,646 CONSOLIDATED SEGMENT REVENUE DETAIL (dollars in thousands) Three Months Ended March 31, 2009 2008 DBM $14,026 $16,966 Hybrid/Synthetic 748 644 Traditional Tissue 5,277 5,110 Spinal Allografts 1,880 2,250 Client Services 1,633 2,424 Other Product Lines 367 237 Revenue $23,931 $27,631 CONDENSED CONSOLIDATED BALANCE SHEETS (dollars in thousands) March 31, December 31, 2009 2008 Assets Cash and cash equivalents $13,697 $18,823 Accounts receivable, net 20,815 17,968 Deferred processing costs 42,689 38,715 Inventories 1,970 1,467 Other current assets 2,051 3,115 Total current assets 81,222 80,088 Property, plant and equipment, net 33,128 34,005 Other assets
'/>"/>
SOURCE Osteotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
7. Osteotech to Present at the Sidoti Conference in New York
8. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
9. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
10. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
11. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014 Egenix, Inc. is pleased to ... Chairman of the Board, to succeed Donald Fresne ; ... will continue as a member of the Board.  In recognition ... to the company over almost twenty years, the Board designated ... of Directors has established a Search Committee to find a ...
(Date:12/17/2014)... USA (PRWEB) December 16, 2014 ... manager at Philipps- Universität Marburg’s Department of Physics, ... photonics, in the newly released SPIE Women ... never be too shy to ask questions.” , ... technology, engineering, and mathematics) occupations ranging from university ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... we didnt spend so much time trying to be the next ... Wisconsins technology roadmap is to become a Midwest carbon copy of ... differences in business, labor and general population are so vast that ... and still not come close. If its true that the ...
... , WTN: What's the next big thing in technology? E-commence? ... will be the continuous improvements in CRM tools and software. ... better connecting customers with companies and institutions. All of ... element that surrounds our customers. Doing so will result ...
... about weblogs - until now. Truth be told - and probably ... bandwagons. If everyone is going right, I'll move left just to ... on blogging was that it was just another technology-enabled fad. Any ... other fool could read it. Of course, there was, initially, a ...
Cached Biology Technology:What If We Cut Our Own Path? 2What If We Cut Our Own Path? 3The Next Big Thing in E-Commerce - Guild.com CEO comments on Wisconsin's technology vision 2The Blog Nation 2The Blog Nation 3
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... the coralline algae fossils that lived on the last coral ... years ago. Mediterranean algae and coral reefs began to resemble ... the Indian Ocean and global cooling 15 and 20 million ... University of Granada (UGR) and the University of Modena and ...
... A study comparing how two common dietary oil ... themselves, can lower body fat in obese postmenopausal women ... were safflower oil, a common cooking oil, and conjugated ... meat and dairy products that has been associated with ...
... Antonio Medical mycologists in The South Texas Center ... Biology at The University of Texas at San Antonio ... Valley Fever, a respiratory infection of humans, commonly called ... fungus. For the first time, the researchers ...
Cached Biology News:Coralline algae in the Mediterranean lost their tropical element between 5 and 7 million years ago 2Two dietary oils, two sets of benefits for older women with diabetes 2Two dietary oils, two sets of benefits for older women with diabetes 3Two dietary oils, two sets of benefits for older women with diabetes 4UTSA infectious disease researchers advancing vaccine against Valley fever 2
Request Info...
... the Art GLP facility with capabilities ... L fermentation. Coordinated process development ... Aseptic operation capable of simultaneous production ... Modes. Hosts include: Bacteria, Yeast, ...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
TRBP1 Antibody...
Biology Products: